Skip to main content

Rhythm Therapeutics

Rhythm Therapeutics, a startup based on Northwestern cardiologist Dr. Rishi Arora's research, is creating a next generation gene therapy targeting the molecular mechanisms underlying atrial fibrillation with the potential to be more effective than current standard-of-care treatments including drugs and ablation.

Rhythm Therapeutics Company website